WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
THB 5.20
0.00%
(0.00) 1D
Oct 15, 4:40:00 PM GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for WUXI06...
Open
THB 5.25
High
THB 5.35
Low
THB 5.05
Mkt. cap
205.18B
Avg. vol.
93.60K
Volume
288.50K
52-wk high
THB 6.25
52-wk low
THB 3.02
Shares outstanding
4.12B
No. of employees
15K
Open
THB 5.25
High
THB 5.35
Low
THB 5.05
Mkt. cap
205.18B
Avg. vol.
93.60K
Volume
288.50K
52-wk high
THB 6.25
52-wk low
THB 3.02
Shares outstanding
4.12B
No. of employees
15K
News stories
From web sources and news partners
marketscreener.com
·
25 minutes ago
S&P 500 index rose slightly after Stockholm exchange close Thursday
Yahoo Finance
·
2 hours ago
The S&P 500 Went More Than 50 Trading Days Without a 1% Drop. That Streak Just Ended. What's Next?
Traders Union
·
3 hours ago
S&P 500 may reach 10,000 by 2027, James E. Thorne predicts
Profile
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
About Wuxi Biologics (Cayman) Inc. KKPS DR